Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Aaron Kesselheim and Jerry Avorn.
Aaron Kesselheim
Connection Strength
2.511
Jerry Avorn
  1. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19. Health Aff (Millwood). 2021 01; 40(1):25-32.
    View in: PubMed
    Score: 0.914
  2. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval. N Engl J Med. 2020 Oct 29; 383(18):1706-1708.
    View in: PubMed
    Score: 0.903
  3. US Taxpayers Heavily Funded the Discovery of COVID-19 Vaccines. Clin Pharmacol Ther. 2022 03; 111(3):542-544.
    View in: PubMed
    Score: 0.239
  4. Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France. J Law Med Ethics. 2021; 49(1):139-151.
    View in: PubMed
    Score: 0.230
  5. Origins and Ownership of Remdesivir: Implications for Pricing. J Law Med Ethics. 2020 09; 48(3):613-618.
    View in: PubMed
    Score: 0.225
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.